Publication | Closed Access

Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal

ThrombosisVenous ThrombosisThromboembolic EventsCardiovascular DiseaseBlood PlateletClinical EpidemiologyHematologyCoagulopathyOral Anticoagulation ReversalPublic HealthMedicineAnticoagulantAtherosclerosisAnesthesiology